Lil Lytnin’ Strikes Lung Cancer
Tori Tomalia was diagnosed with Stage IV ROS1+ lung cancer in 2013 and developed brain mets in 2015. She made it four years on crizotinib but didn’t get much from lorlatinib. She’s still going strong and pioneering a trail on the clinical trial for repotrectinib.
Outliving Lung Cancer
Linnea is the fourth person ever to take crizotinib. She’s lived with her ALK+ lung cancer since 2005. She’s participated in three clinical trials including lorlatinib and is blazing a trail of survival for folks like me.